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Mastitis remains a major disease of cattle with a strong impact on the dairy industry. There is a growing interest in
understanding how cell mediated immunity contributes to the defence of the mammary gland against invading
mastitis causing bacteria. Cytokines belonging to the IL-17 family, and the cells that produce them, have been
described as important modulators of the innate immunity, in particular that of epithelial cells. We report here that
expression of IL-17A and IL-17F genes, encoding two members of the IL-17 family, are induced in udder tissues of
cows experimentally infected with Escherichia coli. The impact of IL-17A on the innate response of bovine mammary
epithelial cells was investigated using a newly isolated cell line, the PS cell line. We first showed that PS cells, similar
to primary bovine mammary epithelial cells, were able to respond to agonists of TLR2 and to LPS, provided CD14
was added to the culture medium. We then showed that secretion of CXCL8 and transcription of innate immunity
related-genes by PS cells were increased by IL-17A, in particular when these cells were stimulated with live E. coli
bacteria. Together with data from the literature, these results support the hypothesis that IL-17A and IL-17 F could
play an important role in mediating of host-pathogen interactions during mastitis.Introduction
Despite decades of research, mastitis remains a major
concern in dairy farming. Mastitis are mainly due to
bacterial infections (Gram-positive pathogens such as
Staphylococcus aureus and Streptococcus uberis, or
Gram-negative pathogens such as Escherichia coli) [1].
Previous studies have allowed the identification of
key molecular events that ultimately lead to the re-
cruitment of neutrophils in the mammary gland upon
bacterial colonization. When bacteria enter the udder,
the host responds by secreting chemokines (such as
CXCL8, CCL20) and other immune components such
as antimicrobial peptides (LAP—lingual antimicrobial
peptide, TAP—tracheal antimicrobial peptide) and pro-
inflammatory cytokines (TNF-α, IL-1β) [2-4]. Production
of pro-inflammatory cytokines such as IL-1β, IL-6 and
TNF-α and the chemokine CXCL8 have been detected in
milk from clinically affected animals and are supposed to
contribute to the inflammation observed in mastitis [2,4].* Correspondence: pierre.germon@tours.inra.fr
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creativecommons.org/publicdomain/zero/1.0/In vivo experiments indicate that the severity of E. coli
mastitis mainly depends on host factors and that a quick
and efficient response is important for an efficient clear-
ance of the bacteria [5]. This process relies heavily on
the recruitment of neutrophils during infection: a delay
in the recruitment of neutrophils aggravates the infec-
tion [6,7]. It is therefore expected that any mechanism
that modulates the immune response of the host could
participate in the defence against E. coli mastitis.
IL-17A and IL-17F are two cytokines that have been
described as playing a significant role in the recuitment
of neutrophils in other inflammatory diseases. Along
with four other structurally related cytokines, IL-17B,
IL-17C, IL-17D and IL-17E, they form the IL-17 family [8].
Although expression of IL-17A and IL-17F may be
detrimental to the host, in particular in the case of
autoimmune diseases, they have been shown to be
beneficial to the host to fight against bacterial pathogens
such as Citrobacter rodentium, Klebsiella pneumoniae or
Escherichia coli [8,9].
Production of IL-17A during S. uberis mastitis was re-
cently demonstrated [10]. Tao and Mallard also reported
that IL-17A gene expression was slightly increasedrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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) applies to the data made available in this article, unless otherwise stated.
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infected cows [11]. Microarray analyses of MEC stimu-
lated with S. aureus culture supernatant also showed
induction of the IL-17A pro-inflammatory pathway [12].
In addition, we recently demonstrated that, in vitro,
IL-17A increases the ability of mammary epithelial cells
(MEC) to respond to agonists similar to that produced
by S. aureus [13]. These cells are thought to play a sig-
nificant role in the defence against invading pathogens
by producing antimicrobial peptides as well as cytokines
and chemokines such as CXCL8 and IL-6. Indeed, in vitro
grown primary bovine MEC (pbMEC) have been shown
to respond to the presence of bacteria, such as E. coli or S.
aureus, or to different purified bacterial agonists by pro-
ducing different cytokines, chemokines or antimicrobial
peptides [12,14-18].
Based on these data, one could hypothesize that IL-17
cytokines contribute to the innate response of the host
during E. coli mastitis; but this remains to be studied.
In the present report, we thus decided to investigate,
under controlled conditions, whether expression of genes
encoding cytokines of the IL-17 family was induced upon
intra-mammary infection of cows by E. coli. We then
explored how this over-expression of IL-17A gene could
translate in terms of defence against the invading patho-
gen. Using a new cell line, called the PS cell line, which we
characterized in details in terms of phenotypic markers
and response to bacterial agonists, we analysed the influ-
ence of IL-17A on the innate immune response of MEC
to infection by E. coli.
This report brings a new perspective on the cellular
features and molecular parameters involved in the ability
of MEC to take part in the udder defence against mastitis.
Materials and methods
Ethics statement
Experimental infection of animals were conducted at the
Clinic for Ruminants (Munich, Germany) with the ap-
proval of the ethics committee of the regional government
of upper Bavaria, Germany (No. 55.2-1-54-2531-108-05).
Experimental infection of cows
Five healthy German Holstein Frisian first lactation cows
in mid lactation (3-6 months after parturition) fulfilling
criteria as previously described [19] were inoculated in
one quarter with 500 cfu E. coli strain 1303. Five heifers
that received no treatment served as untreated controls.
Only animals without previous diagnosis of clinical
or subclinical mastitis and a reported somatic cell
count <50 000/mL were included in the study. Quarter
milk samples were collected and tested weekly before
the trial to ensure that they contained <50 000 somatic
cells/mL and were free of mastitis pathogens. Animals were
randomly assigned to both groups and the experimentswere carried out between March and December. All E.
coli inoculated animals developed clinical mastitis in the
affected quarter 12 h after inoculation as previously de-
scribed [19]. Animals were slaughtered 24 hours post-
inoculation (hpi). Liquid nitrogen snap frozen udder
samples of lobulo-alveolar tissue 7 cm dorsal of the milk
cistern were obtained immediately after slaughtering.
RNA was isolated from approx. 100 mg of frozen udder
tissue using Trizol (Invitrogen). The sample was placed
in a 2 mL tube containing 1.4 mm beads (MP Biomedi-
cals) and one mL of Trizol was added. Tissue lysis was
obtained by shaking the tubes twice in a FastPrep apparatus
(MP Biomedicals) for 45 s at speed 6. The homogenate was
further processed as recommended by the manufacturer.
RNA quality was checked using an Agilent Bioanalyzer
and only samples with a RNA Integrity number above 7
were used. Controls included RNA samples from the
uninoculated quarters from inoculated cows as well as
samples from quarters of non-inoculated cows.
Isolation and culture of PS cells
The whole mammary gland was isolated from a Prim’-
Holstein dairy cow. The cow was killed at the slaughter-
house of the INRA dairy facility as part of a routine
killing at the end of its 6th lactation. The cow was killed
following the recommended guidelines of the American
Veterinary Medical Association (“AMVA Guidelines for
the Euthanasia of Animals”): first the cow was eutha-
nized using a penetrating captive bolt and killed by
exsanguination by the authorized personnel of the
slaughterhouse. The mammary gland was removed and
transferred to the laboratory for further processing.
Pieces of tissue were dissected in the secretory paren-
chyma and placed in Hank’s Balanced Salt Solution
(HBSS, Lonza) containing 200 U/mL penicillin (Sigma-
Aldrich), 200 μg/mL streptomycin (Sigma-Aldrich), 0.5 μg/
mL amphotericin B (Gibco). Tissue fragments of 10 g were
washed with HBSS and minced with surgical scissors. The
small tissue cubes were washed and incubated at 37 °C
under slight agitation in 30 mL HBSS containing 5.5 U/mL
protease from Streptomyces griseus (Sigma-Aldrich). Every
30 min, the dispersed cells were harvested from the mixture
by filtration through a 200 μm nylon mesh and fresh en-
zymatic preparation was added to the remaining tissue frag-
ments. Cells used in this study were obtained after 2 h of
incubation with pronase. Cells were cultured at 37 °C in
5% CO2 in Advanced DMEM/F12 medium (Gibco) con-
taining 10% fetal calf serum (FCS), 2 mM L-glutamine,
40 mMN-(2-hydroxyethyl)-piperazine-N′-2-ethanesulfonic
acid (HEPES buffer, Biowhittaker), 200 U/mL penicillin
(Sigma-Aldrich), 200 μg/mL streptomycin (Sigma-Aldrich),
0.5 μg/mL amphotericin B (Gibco) and 1 μg/mL hydrocor-
tisone (Sigma-Aldrich). After 24 h, attached cells were
washed with HBSS and fresh medium was added. After
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trypsinization (0.25% trysin-EDTA). Detached cells after
5 min of trypsinization were discarded and fresh medium
was added on the cells that remained attached to the plastic
of the culture flasks. This selective trypsinization was re-
peated on day 6 and a first passage was performed two days
later. Cells were then frozen under nitrogen after 2 pas-
sages. The PS cell line was obtained by selective trypsiniza-
tion at passage 4. The cells were subjected to 2 additional
passages and frozen.
Cells were thereafter maintained in MEC growth
medium (GM): Advanced-DMEM/F12 (Gibco) contain-
ing 20 mM HEPES, 2 mM L-glutamine (Gibco), 1 μg/
mL hydrocortisone (Sigma-Aldrich), 10 ng/mL Insulin-
like growth factor (IGF)-1, 5 ng/mL Fibroblast growth
factor (FGF), 5 ng/mL Epidermal growth factor (EGF).
Cytology of the PS cell line
In order to visualize the morphological features of the
PS cell line in culture, a May-Grünwald Giemsa staining
was performed on cells grown on 6-well plate. Cells
were covered with May-Grünwald dye for 3 min. The
same volume of distilled water was added for 1 min. After
draining, Giemsa dye (8% in distilled water) was incubated
for 20 min and the cells were washed with tap water.
Flow cytometry analysis of PS cells
Antibodies used in the present study are described in
Additional file 1. Labellings were done on PS cells at
passages 9, 14 and 18. Intracellular labelling for cytoker-
atins expression study was performed when cells formed
a confluent monolayer. Cells were harvested after trypsin
treatment (0.05% trysin-EDTA -Gibco), and the cell pel-
let was resuspended in 500 μL of permeabilization buffer
Cytofix Cytoperm (BD Biosciences), and incubated in
the dark at 4 °C. After 20 min, the cell suspension was
washed with 1 mL of Perm Wash 1X buffer (BD Biosci-
ences). The cells were collected, resuspended in Perm
Wash 1X buffer, and were split into each well (3 × 105/
well in 20 μL) of a 96-well U-bottom well plate. The
cells were then incubated with 20 μL of primary anti-
body for 15 min at 4 °C. The plate was washed with
100 μL of Perm Wash buffer, and the cell pellet was re-
suspended in 50 μL of the secondary antibody for
15 min at 4 °C when required.
Extracellular labelling was performed when MEC
formed a confluent monolayer. Cells were harvested and
distributed (20 μL, 3 × 105 cells/well) into 96-well U-
bottom well plates. The cell suspension was resuspended
in 20 μL of antibodies against CD45, CD14 and CD282
(TLR2), and incubated for 15 min at 4 °C. The cells were
then washed with 100 μL of buffer (DPBS without Ca
and Mg, Lonza; 2% goat serum, Gibco; 2 mM EDTA).
The plate was centrifuged for 10 min at 200 g, and, ifnecessary, the cell pellet was resuspended in 50 μL of
secondary antibodies, and incubated for 15 min at 4 °C.
Then the cells were washed and fixed with 150 μL of
FACS lysing solution (BD Biosciences). Peripheral blood
mononuclear cells (PBMC) isolated from bovine blood
were used as positive control for CD45 labelling.
Fluorescence-activated cell sorting (FACS) analysis was
performed on a FACSCalibur cytometer using CellQuest
software (BD Biosciences) and data were analyzed with
FlowJo software (Tree Star, Ashland, OR, USA).
Stimulation of cells with live bacteria or purified bacterial
agonists
For each stimulation assay, each stimulus/strain was
assessed in duplicate wells. PS cells were seeded at a
concentration of 105 cells/mL in 24-well or 96-well
plates and cultivated in GM medium until they formed a
confluent monolayer. They were then cultured overnight
(16 h) in fresh stimulating medium without growth fac-
tors (stimulation medium). Cells were then washed twice
with HBSS and stimulated with either live bacteria or
bacterial purified agonists diluted in stimulation medium
at the indicated concentrations. For stimulation with E.
coli strains 1303 or P4 [20], bacteria were grown over-
night in stimulation medium at 37 °C without agitation.
On the day of the experiment, bacteria were diluted in
stimulation medium and added to cells at a multiplicity
of infection of 1. Cells were incubated with bacteria for
three hours at 37 °C in a humidified incubator with 5%
CO2; bacteria were then removed, cells were washed
twice with HBSS and stimulation medium containing
10 μg/mL gentamycin was added. Supernatant was
collected 5 h or 21 h after addition of the gentamycin
containing medium and cells were processed for RNA
purification if necessary (see below). Agonists used were
from InvivoGen: ultrapure lipopolysaccharide from E.
coli O111:B4 strain (LPS), γ-D-glutamyl-meso-diamino-
pimelic acid (C12-iE-DAP), Pam2-CSK4, Pam3-CSK4,
muramyl-dipeptide (MDP) and flagellin (FLA-ST Ultra-
pure). Cells were incubated with these purified agonists
for 5 h at 37 °C in a humidified incubator with 5% CO2;
supernatants were then collected and cells were proc-
essed for RNA purification if necessary. For RNA isola-
tion, cells were lysed with RA1 lysing buffer (Macherey-
Nagel) with 1% β-mercaptoethanol (Sigma-Aldrich).
RNA was then extracted following the manufacturer’s
instructions (Macherey-Nagel). When required, 5 μg/mL
of recombinant human soluble CD14 (CD14) (Biometec
GmbH, Germany), 5 μg/mL of recombinant human
LPS-binding protein (LBP) (Biometec GmbH) or fresh
whole milk were used to supplement the culture medium
of PS cells. Fresh whole milk was collected on the day of
the experiment from a healthy Prim’Holstein cow from
the Unité Expérimentale de Physiologie Animale de
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previously at a concentration of 100 ng/mL [13]. Primary
cells were isolated and grown as previously described and
used at their third passage [16,21,22].
ELISA assays
CXCL8, IL-17A and TNFα production by PS cells was
quantified by sandwich ELISA, with reference to stand-
ard as described previously [23,24]. IL-1β was quantified
by ELISA using the Bovine IL-1 beta ELISA Reagent Kit
(Thermo Scientific).
Transcript analysis by RT-PCR and RT-qPCR
Total RNA (1 μg) was reverse transcribed to cDNA
using random hexamers and SuperScript RT III (Invitro-
gen) according to manufacturer’s instructions. Primers
used in this study are listed in Additional file 2 and [13].
Expression of PRRs was analyzed by RT-PCR using 40
amplification cycles. Relative quantities of transcripts of
interest were analyzed by RT-qPCR as described previously
[13]. Briefly, after normalization using the expression of 3
reference genes (Actb, PPIA, 18S RNA), expression of each
gene was calculated relative to the values obtained from
unstimulated cells arbitrarily set to 1.
Statistical analysis
In vivo gene expression results were analysed by a per-
mutation test using the StaXact software (v5.0—Cytel
software) to obtain exact p-values. For the analysis of re-
sponses of MEC cells to the different bacterial agonists
or to live bacteria, data were first compared using the
Kruskal and Wallis test followed by exact permutation
tests using StatXact. A p-value < 0.05 was considered
significant.
Results
IL-17A and IL-17 F gene expression is induced upon
infection of the udder by E. coli
Previous reports showed that experimental intra-
mammary inoculation of Escherichia coli 1303 induced a
significant host response [25]. Based on microarray ana-
lyses, expression of cytokines and chemokines such as
CCL20 and CXCL8 was shown to be increased upon E.
coli 1303 infection 514 and 58-fold, respectively [15].
Our RT-qPCR data confirmed that, upon infection with
E. coli 1303, expressions of CCL20 and CXCL8 genes
were induced, approx. 16 000-fold and 108-fold, respect-
ively (Figures 1A and B). A higher expression, compared
to uninfected cows, was also detected, particularly with
CCL20, in uninfected quarters of three out of five E. coli
infected cows which is consistent with a systemic effect
as previously reported [19,26].
Microarray experiments had failed to detect a signifi-
cant expression of IL-17 family genes in udder tissueafter E. coli infection, presumably because of a low ex-
pression of these genes [15]. In the present study, we
thus used RT-qPCR to evaluate the expression of IL-17
family genes. No expression was detected for IL-17C
and IL-17E (data not shown). On the contrary, expres-
sion of IL-17A and IL-17F was significantly increased in
E. coli infected quarters, compared to non-infected quar-
ters (Figures 1C and D): the mean fold-change for IL-17A
was 72 in samples from cows infected by E. coli.
Mean induction of IL-17F was 109-fold in the same
samples (Figures 1C and D). Although induction of IL-
17A gene was clearly observed in our tissue samples, IL-
17A levels in milk samples from E. coli infected cows
were below the detection limit of the ELISA assay used,
that is below 200 pg/mL in milk.
Despite this lack of detection of IL-17A in milk from
infected quarters, gene expression results suggest that
IL-17A and IL-17F may play a role in the immune re-
sponse of cows to intra-mammary infection, either at
the onset of or during the inflammatory response.
Considering that IL-17A has generally more potent
effects than IL-17F on epithelial cells [13], we then ex-
plored if IL-17A in particular could contribute to the de-
fence of the host against E. coli infection by modulating
the innate immune response of MEC. Indeed, these cells
are key players in mounting an efficient early innate im-
mune response and IL17-A has been shown to target a
variety of cell types, in particular epithelial cells [27-29].
PS cells as a useful tool to study the innate immune
response of mammary epithelial cells
Although pbMEC are often used to study the response
of MEC to infection, the use of primary epithelial cell
cultures has a number of drawbacks. Most importantly,
variability of response of pbMEC from different animals
on the one hand and lack of reproducibility of experi-
ments on the other hand, can be associated with con-
tamination of primary cell cultures with other cell types,
and the amount of these contaminating cells can vary
from one primary culture to another. Considering that
these contaminating cells could exacerbate or lower the
innate immune response of MEC through cooperation,
we decided to use a new mammary epithelial cell line
showing innate immune response capabilities to perform
these assays.
This cell line, which we called the PS cell line, stems
from spontaneously immortalized cells that emerged
from a culture of primary bovine MEC isolated from the
secretory parenchyma of a cow (hence the name PS
cells). Upon reaching confluency, they form a homoge-
neous layer of cells with cobblestone morphology typical
of epithelial cells (Additional file 3). This cell line was
also characterized for potential contamination by leuko-
cytes (CD45-positive cells) and for expression of cell
Figure 1 Analysis of gene expression during experimentally induced mastitis. RT-qPCR specific for CCL20 (A), CXCL8 (B), IL-17A (C) and IL-17F
(D) were performed on RNA extracted from tissue samples of udder quarters from uninfected cows or E. coli infected cows. Data presented are
values from five animals with medians and interquartile ranges indicated as vertical bars. * statistical significance (P < 0.05) of infected versus
uninfected cows calculated using exact permutation tests after global comparison using a Kruskal and Wallis test.
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cells. Results indicated a percentage of CD45-positive
cells similar to background level (0.6%) and expression
of cytokeratin 18 by more than 99.5% of cells. Cytokeratin
14 was only weakly expressed by PS cells (Figures 2A-F).
RT-PCR data indicated that these cells expressed
several genes encoding Pattern Recognition Receptors
(PRR) such as TLR1, TLR2, TLR4, TLR6, NOD1 andNOD2 (Figure 2G) as well as the genes encoding the two
subunits of the IL-17A receptor, namely IL-17RA and
IL-17RC (Figure 2H). While the weak amplification of
TLR5 cDNA was consistent with previous results obtained
with primary epithelial cells [16], a weak amplification of
TLR2 cDNA was observed. Despite this low expression of
TLR2, FACS analysis showed that the TLR2 protein was
actually present at the surface of PS cells (Figure 2D).
Figure 2 Characterization of PS cells properties by flow cytometry and RT-PCR. PS cells, at passage 14, were labelled with antibodies against
CD45 (A), cytokeratin 14 (B), cytokeratin 18 (C), TLR2 (D) and CD14 (E). Controls were performed either by omitting the primary antibody (A, B, C)
or using unlabelled cells (D, E). As a control for CD45 labelling, bovine PBMC were labelled with the anti-CD45 antibody (F). Labelled cells are depicted
as red curves while controls are represented as blue curves. (G-H) RNA was extracted from unstimulated PS cells and converted to cDNA. cDNAs
for each of the indicated receptors were amplified by PCR and products were separated by agarose gel electrophoresis. MW: 50 bp molecular
weight ladder.
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response, we analysed their capacity to respond to stim-
uli such as lipopolysaccharide (LPS), lipoteichoic acid
(LTA), lipoproteins or peptidoglycan degradation products.
The synthetic molecules Pam2-CSK4 and Pam3-CSK4
are analogs of di-acylated and tri-acylated lipoproteins
that signal through the TLR2/TLR6 or TLR1/TLR2heterodimers, respectively. C12-iE-DAP and MDP are
peptidoglycan subunits that are sensed by the NOD1 and
NOD2 receptors, respectively. When PS cells were ex-
posed to these MAMPs, the highest response was
observed with Pam2-CSK4 at 100 ng/mL (Figure 3): com-
pared to non-induced cells, Pam2-CSK4 induced an over-
expression of CCL20, CXCL8 and TAP, three genes whose
Figure 3 Innate immune response of PS cells to different purified bacterial agonists. PS cells were incubated for 5 h with the indicated
concentrations of different purified agonists. Response was analyzed in terms of expression of CCL20 (A), CXCL8 (B), TAP (C), LAP (D) genes
by RT-qPCR or CXCL8 secretion by ELISA (E,F). Data presented are mean values and SD obtained from 3 independent experiments. Experiments
were performed at passages 11, 12 and 24. PS cells were incubated for 5 hours in GM medium with different agonists at the indicated concentrations.
(F) PS cells were incubated with ultrapure LPS (LPS) at 10 ng/mL in the presence of either 10% fetal calf serum, 5 μg/mL CD14 or 5 μg/mL LBP. Stimulation
was also performed in whole milk instead of GM medium. * statistical significance (P < 0.05) of stimulated versus unstimulated PS cells using
exact permutation tests after global comparison using a Kruskal and Wallis test.
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thelial cells [15], and induced also the secretion of CXCL8
(Figure 3E). PS cells also responded to Pam2-CSK4 when
used at 10 ng/mL (data not shown). A significant but
lower response was observed with Pam3-CSK4, both in
terms of increased expression of CCL20, CXCL8, TAP and
LAP and increased secretion of CXCL8 (Figure 3). No re-
sponse was observed with both MDP and C12-iE-DAP
(Figure 3). In a separate experiment, a concentration of
flagellin of 100 ng/mL only induced a weak increase in
TAP expression (3-fold) but failed to induce significant se-
cretion of CXCL8 and increased expression of CCL20(data not shown). Interestingly, response of PS cells to LPS
required the addition of CD14 in the culture medium.
Under serum-free conditions, PS cells responded only
weakly to LPS. Nevertheless, CXCL8 secretion in response
to 10 ng/mL LPS was increased in the presence of 5 μg/mL
CD14 (1067 pg/mL) compared to only 67 pg/mL in the
absence of CD14 (Figure 3E). On the contrary, supplement-
ing the medium with LBP did not improve the response of
PS cells to LPS. This indicates that CD14 is essential for the
recognition of LPS by the PS cell line in our culture condi-
tions. In the presence of serum (10% FBS), the PS cells
produced CXCL8 in response to LPS, and CXCL8
Figure 4 IL-17A effect on the response of PS cells to Pam3-CSK4.
PS cells were incubated for 5 h with 100 ng/mL of Pam3-CSK4 in
the presence or not of 100 ng/mL IL-17A. Response was analyzed in
terms CXCL8 secretion (A) by ELISA or expression of CCL20 (B) and
CXCL8 (C) by RT-qPCR. Data presented are mean values and SD
obtained from 3 independent experiments. Experiments were
performed at passages 15, 16 and 24. * statistical significance
(P < 0.05) calculated using exact permutation tests after global
comparison using a Kruskal and Wallis test.
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performed in fresh milk (Figure 3). This is in keeping with
the occurrence of sCD14 in serum and bovine milk [30].
Compared to the response of primary cells to these
same agonists, PS cells responded to a similar array of
bacterial compounds, although their response was some-
what lower than that of pbMEC (Additional file 4). Fur-
thermore, stimulation experiments performed at different
passages indicated that the PS cell line is stable at least up
to passage 24 (Additional file 4).
PS cells could thus be used as a surrogate to pbMEC
to monitor the innate response of mammary epithelial
cells and, in the present report, how this response can
be modulated by IL-17A.
IL-17A increases the response of PS cells to Pam3-CSK4
In a first attempt to investigate how IL-17A could modu-
late the response of MEC, we analysed the response of PS
cells to purified bacterial agonists in the presence or not
of IL-17A. We selected LPS and Pam3-CSK4, activating
TLR4 and TLR1/2, respectively, as they are likely to repre-
sent the most relevant agonists in vivo through which E.
coli stimulates MEC and they induce a strong innate re-
sponse in pbMEC [16] and PS cells (see Figure 3).
When PS cells were stimulated with both Pam3-CSK4
and IL-17 for 5 hours, the response in terms of CCL20
and CXCL8 gene expression was significantly increased
compared to the response observed only in the presence
of IL-17A or Pam3-CSK4 (Figure 4). The increase in
terms of CXCL8 secretion, although significant statisti-
cally, was less important. The impact of IL-17A on the
response of PS cells to LPS was also statistically signifi-
cant but of lower magnitude. A clear response of PS cells
to LPS was observed in the presence of CD14 with high
level of secretion of CXCL8 and strong induction of
CCL20 and CXCL8 gene expression (Figure 5). Secretion
of CXCL8 was increased 1.5 fold when IL-17 was present
along with LPS and CD14. In the same conditions, IL-
17A induced only a small increase of CCL20 gene expres-
sion while no significant impact on CXCL8 gene
expression was observed. Interestingly, although PS cells
responded very weakly to LPS in the absence of CD14,
we could observe that IL-17 increased slightly the re-
sponse of PS cells when they were stimulated with LPS
alone (Figure 5).
IL-17A increases the response of MEC to live E. coli
We next analysed if IL-17A could also increase the re-
sponse of MEC to live bacteria. We used a protocol pre-
viously described which allowed stimulation of cells with
live bacteria while avoiding a change in pH of the cul-
ture medium due to bacterial outgrowth [21]: briefly,
cells were incubated in the presence of bacteria for three
hours. Bacteria were then washed away, medium containing
Figure 5 IL-17A effect on the response of PS cells to LPS. PS cells were incubated for 5 h with 10 ng/mL of LPS in the presence or not of 100 ng/mL
IL-17A and 5 μg/mL CD14. Response was analyzed in terms CXCL8 secretion (A) by ELISA or expression of CCL20 (B) and CXCL8 (C) by RT-qPCR. Data
presented are mean values and SD obtained from 3 independent experiments. Experiments were performed at passages 15, 16 and 24.
* statistical significance (P < 0.05) calculated using exact permutation tests after global comparison using a Kruskal and Wallis test.
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tion was prolonged for 5 h (for RT-qPCR analyses) or 21 h
(for ELISA assays of CXCL8 secretion).
Results indicated that IL-17A increased the response
of PS cells when they were stimulated with either E. coli
strain 1303 or E. coli P4, a prototypical mastitis isolate.
Expression of CCL20, CXCL8 and TAP were signifi-
cantly increased upon addition of IL-17A in the culture
medium (Figure 6). Similarly, secretion of CXCL8 was
increased 1.5 fold and 3.1 -fold in PS cells stimulated
with strains 1303 and P4, respectively (Figure 6D).We observed a similar increase in innate response me-
diated by IL-17A using primary cells (Figures 6E-F). An
increase in CXCL8 secretion was observed with primary
cells from two different cows using E. coli P4 and, to a
somewhat lower extent, with E. coli 1303. These results
indicate that the increased pro-inflammatory response
triggered by IL-17A is not restricted to PS cells. In
addition, the fact that these primary cells do not require
addition of CD14 in the medium to respond to LPS [16]
suggests that the effect of IL-17A does not depend on
supplementation of the medium with CD14.
Figure 6 IL-17A increases the secretion of CXCL8 by PS cells upon stimulation with E. coli strains 1303 and P4. A-D: PS cells were incubated for
3 hours with strain E. coli 1303 or P4 at an MOI of 1. Cells were then washed twice with HBSS and medium with gentamycin was added with or
without 100 ng/mL IL-17A. Response was analysed in terms of gene expression (CCL20: A, CXCL8: B, TAP: C) or CXCL8 secretion by ELISA (D) after
beginning of the experiment. Data presented are mean values and SD obtained from 3 independent experiments. Experiments were performed
at passages 8, 26 and 30. E-F: primary mammary epithelial cells from two cows were incubated for 3 hours with strains E. coli 1303 and P4 at an
MOI of 1. Cells were then washed twice with HBSS and medium with gentamycin was added with or without 100 ng/mL IL-17A. CXCL8 secretion
was measured by ELISA 24 hpi. Data presented are mean values obtained with cells stimulated in triplicates. * statistical significance (P < 0.05)
calculated using exact permutation tests after global comparison using a Kruskal and Wallis test.
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scribed with IL-1β and TNFα we quantified IL-1β and
TNFα in the supernatant of stimulated PS cells: amounts
of IL-1β and TNFα were below the detection limit of the
ELISA assays used (50 pg/mL for TNFα and 30 pg/mL
for IL-1β).
Discussion
The main objective of this report was to investigate if
cytokines of the IL-17 family could play a role in the
defence of cows against intramammary infections. This
question is of particular relevance given the important
role of IL-17 proteins in the defence of different hosts
against a range of bacterial infections [28,31]. In addition,
several reports indicate that IL-17 can be detected in bo-
vine milk in different experimental settings. Production of
IL-17A was recently demonstrated in the course of S.
uberis infection [10]. Furthermore, vaccination of cows
with a model antigen could induce a Th17 cell-mediated
immune response characterized by the production, in par-
ticular, of IL-17A in the mammary gland [24]. The udder
has therefore the ability to secrete IL-17A but its contribu-
tion to the defence against E. coli mastitis has not been
investigated.
From the data presented in this report, we can clearly
conclude that expression of IL-17A and IL-17F genes is
induced approx. 100-fold upon infection by E. coli. We
were however unable to detect any secretion of IL-17A
in milk from E. coli infected quarters. So far, production
of IL-17A in an infected udder was only reported in clin-
ical mastitis after experimental Streptococcus uberis in-
fection. Yet, IL-17A only reached significant levels after
56 h (peak level at 81 h), long after other cytokines had
reached the peak level [10]. It is therefore possible that
IL-17A levels could be detected in milk at later time
points in the case of E. coli infections, explaining our
failure to measure IL-17A in milk from E. coli infected
cows 24 hours post-infection. Preliminary results indi-
cates that expression of IL-17A and IL-17F genes is also
induced in samples from quarters infected by the S. aur-
eus strain 1027 (data not shown). Overall, expression of
IL-17A and IL-17F genes during infection raise the point
of the contribution of these cytokines to the defence of
the udder against bacterial infection.
These cytokines are generally considered to act on
epithelial cells as well as on endothelial and stromal
cells by inducing, for example, expression of anti-
microbial peptides and neutrophil-activating molecules
[31]. We recently showed that, in vitro, IL-17A and IL-
17F were likely to improve the innate defences of the
host through modulation of gene expression patterns
of MEC [13]. More precisely, primary MEC express IL-
17A and IL-17F receptor genes and respond to the
presence of IL-17A by increased expression of differentpro-inflammatory mediators such as CXCL8, CCL20,
IL-6 or IL-1β [13].
We therefore chose to investigate in more details if IL-
17A could increase the response of the host to E. coli in-
fection by modulating the pro-inflammatory response of
MEC. To achieve this goal, we used a new cell line that
we recently isolated. Prior to performing experiments
with IL-17A, we characterized these cells in terms of
expression of markers typical for MEC and in terms of
response to purified compounds, as we had already done
with primary cells [16].
The PS cell line was found to be stable, in terms of cell
morphology (data not shown) and response to MAMPs,
and displays a cobblestone aspect which is consistent
with epithelia characteristics. The strong surface expres-
sion of CK18 and the low expression of CK14 allowed
us to establish that PS cells are effectively from epithelial
origin and of luminal nature [32-35]. The luminal char-
acter of PS cells is also indicated by the fact that PS cells
formed unorganized clones and express PRRs [17,36].
The high percentage of CK18-positive cells, along with
the lack of CD45 labelling, attested to the purity of this
cell line and the absence of leukocytes. Additionally,
these cells were shown to express α–casein gene CSN1S1,
a proof of their secretory capacity, in accordance with
their origin (i.e. secretory parenchyma) (E. Devinoy, M.
Nguyen, personal communication).
Similar to pbMEC, PS cells express several PRRs, in-
cluding TLR1, TLR2, TLR4, TLR6, NOD1 and NOD2
[16,25,36,37]. Consistent with the expression of TLR1,
TLR2, TLR4 and TLR6, PS cells were able to respond to
the presence of bacterial agonists that stimulates through
these receptors such as the analogs of lipoproteins Pam
2-CSK4 and Pam 3-CSK4, and LPS provided CD14 is
added in the culture medium.
Actually, the response of PS cells to LPS in the ab-
sence of CD14 was rather weak compared to what had
already been described [16,37-39] and given the strong
inflammation triggered by LPS infusion in the udder
[40-42]. Supplementing our stimulation medium with
purified CD14, or raw milk, resulted in a substantial in-
crease of the immune response of PS cells to LPS.
Others have reported similar findings with pbMEC [30].
These data suggest that the presence of CD14 in milk
contributes to the response of MEC to LPS and concur
with the observations that 1) concentrations of CD14 in
milk are less than optimal and 2) that response of the
host can be improved when CD14 is infused into the
udder along with the E. coli inoculum [43].
As for flagellin, the absence of TLR5 transcript ob-
served either with PS cells or primary MEC, along with
the weak response induced by purified flagellin, are in
agreement with previous in vitro and in vivo studies
that suggest that flagellin is not a major contributor to
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tion [16,44].
The possibility that PS cells would de-differentiate
after several passages, as was observed by Gunther
et al. [15], was ruled out by showing that PS cells were
still capable of inducing LAP expression upon stimula-
tion with MAMPs.
Altogether, these results indicate that PS cells are use-
ful surrogates to pbMEC in the understanding of innate
immune response of MEC to MAMPs.
After having verified that PS cells expressed the
genes encoding for the two sub-units of the IL-17A re-
ceptor, we used PS cells to investigate whether IL-17A
could contribute to an increased innate immune response
of MEC upon stimulation with purified bacterial com-
pounds. Our results demonstrate that this could be the
case as secretion of CXCL8, as well as expression of
CCL20 and CXCL8 genes, are significantly increased
when cells are incubated for 5 hours with IL-17A and
purified Pam3-CSK4 or, to a lower extent, LPS. We were
only able to detect an additive effect with no real
synergy.
More interestingly, a synergy between IL-17A and in-
nate response of MEC was observed when stimulation
was performed with live bacteria. These results, initially
obtained with PS cells, were confirmed with primary
cells and extend the ones we obtained previously with
purified bacterial compounds related to Gram-positive
bacteria, i.e. MDP and LTA [13].
Our results are reminiscent to synergy observed with
other mediators such as TNFα or IL-1β. [45-47]. Yet,
we did not detect any IL-1β nor TNFα after stimulation
of PS cells with live E. coli. It is therefore unlikely that
production of these pro-inflammatory mediators could
explain the synergies we observed. To explain such re-
sults, one should take into account the multiple activities
of IL-17A both on induction of expression and on
stabilization of mRNA transcripts.
The increased response of PS cells is most likely due
to the stabilization of mRNA transcripts following IL-
17A recognition as was observed for CXCL1 [48-50]. It
could also be due to an increased expression of PRR
genes such as TLR2 or TLR4. A third alternative is that
expression of the IL-17A receptor at the surface of PS
cells is increased after infection by E. coli. Yet, in the ab-
sence of suitable reagent, such a possibility cannot be
tested. The origin of the synergy observed will have to
be further investigated.
Another major issue concerns the characterization
of the cells that overexpress the genes for IL-17A and
IL-17F upon E. coli infection. Immunocytochemistry
analyses suggested that MEC or interstitial cells, pre-
sumably lymphocytes, could produce IL-17A upon
inflammatory challenge [24]. Interestingly, one of thegenes assayed in our work, CCL20, encodes a ligand
for the CCR6 receptor which is expressed by effector
memory T cells, including Th17 cells [51]. As a conse-
quence, the increased expression of CCL20 that we
detected in our assays could also participate to the
amplification of the host response to infection by
attracting more IL-17-producing T cells to the site of
infection.
In conclusion, our results show a marked overexpres-
sion of the genes encoding IL-17A and IL-17F in the
mammary gland during E. coli infections which, by ex-
tending previous observation of overexpression during S.
uberis udder infections, strongly suggest that these cyto-
kines and the cells that produce them are important
players of host-pathogen interactions during mastitis.
Most interestingly, we were able to demonstrate that a po-
tential role for IL-17A is to increase the pro-inflammatory
and antimicrobial responses of MEC after E. coli infection.
These results are also interesting in the scope of vaccine
development. As a matter of fact, the protocol used in
the present manuscript using live bacteria mimics the
in vivo situation encountered by the bacteria entering
the udder of vaccinated animals. In such cases, it is ex-
pected that the first response of MEC occurs in the ab-
sence of IL-17A, IL-17A coming into play only in a
second step when memory Th17 cells have been acti-
vated. Our results are thus a strong incentive to further
investigate the contribution of IL-17A to the defence of
the mammary gland.Additional files
Additional file 1: Antibodies list. List of antibodies used in this study.
Additional file 2: Primer table. List of primers used in this study.
Additional file 3: Microscopic examination of PS cells. A, PS cells
were photographed under phase contrast (100x). B, PS cells after May
Grünwald-Giemsa straining (200x).
Additional file 4: Innate immune response of PS cells and pbMEC
to different purified bacterial agonists. pbMEC from two cows (white
bars) and PS cells at passages 10 and 24 (grey bars) were incubated for
5 h with the indicated concentrations of different purified agonists.
Response was analyzed in terms of expression of CCL20, TAP, LAP and
CXCL8 genes by RT-qPCR. Data are mean values of stimulations performed
in duplicates.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
PG, PRa, PRo, HZ, WP, CR, PC and FBG conceived the study and participated
in its design and coordination. WP carried out all animal experiments. PRa,
PC, FBG and CR isolated PS cells and primary cells. PRo, AP, PC and PG
performed and analyzed stimulation of PS and primary epithelial cells and
expression of PRR data. PRo and PG wrote the manuscript. FBG, PRa and WP
helped writing the final version of the manuscript. All authors read and
approved the final manuscript.
Roussel et al. Veterinary Research  (2015) 46:56 Page 13 of 14Acknowledgments
Dr P. Roussel was recipient of a grant from the “Microbiology and Food
Chain” and “Animal Health” divisions of INRA. We wish to thank Dr Eve
Devinoy and Dr Minh Nguyen for sharing preliminary data.
Author details
1INRA, UMR1282, Infectiologie et Santé Publique, F-37380 Nouzilly, France.
2Université François Rabelais de Tours, UMR1282, Infectiologie et Santé
Publique, F-37000 Tours, France. 3Clinic for Ruminants with Ambulatory and
Herd Health Services at the Centre for Clinical Veterinary Medicine,
Ludwig-Maximilians University Munich, Oberschleissheim, Germany.
Received: 23 October 2014 Accepted: 5 May 2015
References
1. Schukken YH, Gunther J, Fitzpatrick J, Fontaine MC, Goetze L, Holst O, Leigh
J, Petzl W, Schuberth HJ, Sipka A, Smith DG, Quesnell R, Watts J, Yancey R,
Zerbe H, Gurjar A, Zadoks RN, Seyfert HM (2011) Host-response patterns of
intramammary infections in dairy cows. Vet Immunol Immunopathol
144:270–289
2. Riollet C, Rainard P, Poutrel B (2000) Differential induction of complement
fragment C5a and inflammatory cytokines during intramammary infections
with Escherichia coli and Staphylococcus aureus. Clin Diagn Lab Immunol
7:161–167
3. Shuster DE, Kehrli ME Jr, Rainard P, Paape M (1997) Complement fragment
C5a and inflammatory cytokines in neutrophil recruitment during
intramammary infection with Escherichia coli. Infect Immun 65:3286–3292
4. Bannerman DD, Paape MJ, Lee JW, Zhao X, Hope JC, Rainard P (2004)
Escherichia coli and Staphylococcus aureus elicit differential innate immune
responses following intramammary infection. Clin Diagn Lab Immunol
11:463–472
5. Burvenich C, Van Merris V, Mehrzad J, Diez-Fraile A, Duchateau L (2003)
Severity of E. coli mastitis is mainly determined by cow factors. Vet Res
34:521–564
6. Jain NC, Schalm OW, Lasmanis J (1971) Experimentally induced coliform
(Aerobacter aerogenes) mastitis in normal cows and in cows made
neutropenic by an equine anti-bovine leukocyte serum. Am J Vet Res
32:1929–1935
7. Vangroenweghe F, Rainard P, Paape M, Duchateau L, Burvenich C (2004)
Increase of Escherichia coli inoculum doses induces faster innate immune
response in primiparous cows. J Dairy Sci 87:4132–4144
8. Iwakura Y, Ishigame H, Saijo S, Nakae S (2011) Functional specialization of
interleukin-17 family members. Immunity 34:149–162
9. Sivick KE, Schaller MA, Smith SN, Mobley HL (2010) The innate immune
response to uropathogenic Escherichia coli involves IL-17A in a murine
model of urinary tract infection. J Immunol 184:2065–2075
10. Tassi R, McNeilly TN, Fitzpatrick JL, Fontaine MC, Reddick D, Ramage C,
Lutton M, Schukken YH, Zadoks RN (2013) Strain-specific pathogenicity of
putative host-adapted and nonadapted strains of Streptococcus uberis in
dairy cattle. J Dairy Sci 96:5129–5145
11. Tao W, Mallard B (2007) Differentially expressed genes associated with
Staphylococcus aureus mastitis of Canadian Holstein cows. Vet Immunol
Immunopathol 120:201–211
12. Gilbert FB, Cunha P, Jensen K, Glass EJ, Foucras G, Rupp R, Rainard P (2013)
Differential response of bovine mammary epithelial cells to Staphylococcus
aureus or Escherichia coli agonists of the innate immune system. Vet Res 44:40
13. Bougarn S, Cunha P, Gilbert FB, Harmache A, Foucras G, Rainard P (2011)
Staphylococcal-associated molecular patterns enhance expression of immune
defense genes induced by IL-17 in mammary epithelial cells. Cytokine
56:749–759
14. Gunther J, Esch K, Poschadel N, Petzl W, Zerbe H, Mitterhuemer S, Blum H,
Seyfert HM (2011) Comparative kinetics of Escherichia coli- and
Staphylococcus aureus-specific activation of key immune pathways in
mammary epithelial cells demonstrates that S. aureus elicits a delayed
response dominated by interleukin-6 (IL-6) but not by IL-1A or tumor
necrosis factor alpha. Infect Immun 79:695–707
15. Gunther J, Koczan D, Yang W, Nurnberg G, Repsilber D, Schuberth HJ, Park
Z, Maqbool N, Molenaar A, Seyfert HM (2009) Assessment of the immune
capacity of mammary epithelial cells: comparison with mammary tissue
after challenge with Escherichia coli. Vet Res 40:3116. Porcherie A, Cunha P, Trotereau A, Roussel P, Gilbert FB, Rainard P, Germon
P (2012) Repertoire of Escherichia coli agonists sensed by innate immunity
receptors of the bovine udder and mammary epithelial cells. Vet Res 43:14
17. Strandberg Y, Gray C, Vuocolo T, Donaldson L, Broadway M, Tellam R (2005)
Lipopolysaccharide and lipoteichoic acid induce different innate immune
responses in bovine mammary epithelial cells. Cytokine 31:72–86
18. Wellnitz O, Kerr DE (2004) Cryopreserved bovine mammary cells to model
epithelial response to infection. Vet Immunol Immunopathol 101:191–202
19. Mitterhuemer S, Petzl W, Krebs S, Mehne D, Klanner A, Wolf E, Zerbe H,
Blum H (2010) Escherichia coli infection induces distinct local and systemic
transcriptome responses in the mammary gland. BMC Genomics 11:138
20. Bramley AJ (1976) Variations in the susceptibility of lactating and non-lactating
bovine udders to infection when infused with Escherichia coli. J Dairy Res
43:205–211
21. Lahouassa H, Moussay E, Rainard P, Riollet C (2007) Differential cytokine and
chemokine responses of bovine mammary epithelial cells to Staphylococcus
aureus and Escherichia coli. Cytokine 38:12–21
22. Bougarn S, Cunha P, Gilbert FB, Meurens F, Rainard P (2011) Technical note:
Validation of candidate reference genes for normalization of quantitative
PCR in bovine mammary epithelial cells responding to inflammatory stimuli.
J Dairy Sci 94:2425–2430
23. Rainard P, Riollet C, Berthon P, Cunha P, Fromageau A, Rossignol C, Gilbert FB
(2008) The chemokine CXCL3 is responsible for the constitutive chemotactic
activity of bovine milk for neutrophils. Mol Immunol 45:4020–4027
24. Rainard P, Cunha P, Bougarn S, Fromageau A, Rossignol C, Gilbert FB,
Berthon P (2013) T helper 17-associated cytokines are produced during
antigen-specific inflammation in the mammary gland. PLoS One 8:e63471
25. Petzl W, Zerbe H, Gunther J, Yang W, Seyfert HM, Nurnberg G, Schuberth HJ
(2008) Escherichia coli, but not Staphylococcus aureus triggers an early
increased expression of factors contributing to the innate immune defense
in the udder of the cow. Vet Res 39:18
26. Jensen K, Gunther J, Talbot R, Petzl W, Zerbe H, Schuberth HJ, Seyfert HM,
Glass EJ (2013) Escherichia coli- and Staphylococcus aureus-induced mastitis
differentially modulate transcriptional responses in neighbouring uninfected
bovine mammary gland quarters. BMC Genomics 14:36
27. Rainard P, Riollet C (2006) Innate immunity of the bovine mammary gland.
Vet Res 37:369–400
28. Gu C, Wu L, Li X (2013) IL-17 family: cytokines, receptors and signaling.
Cytokine 64:477–485
29. Song X, Qian Y (2013) The activation and regulation of IL-17 receptor
mediated signaling. Cytokine 62:175–182
30. Wang Y, Zarlenga DS, Paape MJ, Dahl GE (2002) Recombinant bovine
soluble CD14 sensitizes the mammary gland to lipopolysaccharide. Vet
Immunol Immunopathol 86:115–124
31. Gaffen SL (2011) Recent advances in the IL-17 cytokine family. Curr Opin
Immunol 23:613–619
32. Pantschenko AG, Woodcock-Mitchell J, Bushmich SL, Yang TJ (2000)
Establishment and characterization of a caprine mammary epithelial cell
line (CMEC). In Vitro Cell Dev Biol Anim 36:26–37
33. Li P, Wilde CJ, Finch LM, Fernig DG, Rudland PS (1999) Identification of cell
types in the developing goat mammary gland. Histochem J 31:379–393
34. Schmid E, Schiller DL, Grund C, Stadler J, Franke WW (1983) Tissue type-specific
expression of intermediate filament proteins in a cultured epithelial cell line
from bovine mammary gland. J Cell Biol 96:37–50
35. Bartek J, Durban EM, Hallowes RC, Taylor-Papadimitriou J (1985) A subclass
of luminal epithelial cells in the human mammary gland, defined by
antibodies to cytokeratins. J Cell Sci 75:17–33
36. Goldammer T, Zerbe H, Molenaar A, Schuberth HJ, Brunner RM, Kata SR,
Seyfert HM (2004) Mastitis increases mammary mRNA abundance of
beta-defensin 5, toll-like-receptor 2 (TLR2), and TLR4 but not TLR9 in cattle.
Clin Diagn Lab Immunol 11:174–185
37. Yang W, Zerbe H, Petzl W, Brunner RM, Gunther J, Draing C, von Aulock S,
Schuberth HJ, Seyfert HM (2008) Bovine TLR2 and TLR4 properly transduce
signals from Staphylococcus aureus and E. coli, but S. aureus fails to both
activate NF-kappaB in mammary epithelial cells and to quickly induce
TNFalpha and interleukin-8 (CXCL8) expression in the udder. Mol Immunol
45:1385–1397
38. Bougarn S, Cunha P, Harmache A, Fromageau A, Gilbert FB, Rainard P (2010)
Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid
to recruit neutrophils in the mammary gland and to stimulate mammary
epithelial cells. Clin Vaccine Immunol 17:1797–1809
Roussel et al. Veterinary Research  (2015) 46:56 Page 14 of 1439. Gunther J, Petzl W, Zerbe H, Schuberth HJ, Koczan D, Goetze L, Seyfert HM
(2012) Lipopolysaccharide priming enhances expression of effectors of
immune defence while decreasing expression of pro-inflammatory cytokines
in mammary epithelia cells from cows. BMC Genomics 13:17
40. Mattila T, Frost AJ (1989) Induction by endotoxin of the inflammatory
response in the lactating and dry bovine mammary gland. Res Vet Sci
46:238–240
41. Paape MJ, Schultze WD, Desjardins C, Miller RH (1974) Plasma corticosteroid,
circulating leukocyte and milk somatic cell responses to Escherichia coli
endotoxin-induced mastitis. Proc Soc Exp Biol Med 145:553–559
42. Jain NC (1979) Common mammary pathogens and factors in infection and
mastitis. J Dairy Sci 62:128–134
43. Lee JW, Paape MJ, Elsasser TH, Zhao X (2003) Recombinant soluble CD14
reduces severity of intramammary infection by Escherichia coli. Infect Immun
71:4034–4039
44. Metcalfe HJ, La Ragione RM, Smith DG, Werling D (2014) Functional
characterisation of bovine TLR5 indicates species-specific recognition of
flagellin. Vet Immunol Immunopathol 157:197–205
45. Andoh A, Takaya H, Makino J, Sato H, Bamba S, Araki Y, Hata K, Shimada M,
Okuno T, Fujiyama Y, Bamba T (2001) Cooperation of interleukin-17 and
interferon-γ on chemokine secretion in human fetal intestinal epithelial cells.
Clin Exp Immunol 125:56–63
46. LeGrand A, Fermor B, Fink C, Pisetsky DS, Weinberg JB, Vail TP, Guilak F
(2001) Interleukin-1, tumor necrosis factor α, and interleukin-17 synergistically
up-regulate nitric oxide and prostaglandin E2 production in explants of human
osteoarthritic knee menisci. Arthritis Rheum 44:2078–2083
47. Granet C, Miossec P (2004) Combination of the pro-inflammatory cytokines
IL-1, TNF-α and IL-17 leads to enhanced expression and additional recruitment
of AP-1 family members, Egr-1 and NF-κB in osteoblast-like cells. Cytokine
26:169–177
48. Datta S, Novotny M, Pavicic PG Jr, Zhao C, Herjan T, Hartupee J, Hamilton T
(2010) IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-
independent sequence. J Immunol 184:1484–1491
49. Hartupee J, Liu C, Novotny M, Sun D, Li X, Hamilton TA (2009) IL-17 signaling
for mRNA stabilization does not require TNF receptor-associated factor 6.
J Immunol 182:1660–1666
50. Hartupee J, Liu C, Novotny M, Li X, Hamilton T (2007) IL-17 enhances chemokine
gene expression through mRNA stabilization. J Immunol 179:4135–4141
51. Sallusto F, Zielinski CE, Lanzavecchia A (2012) Human Th17 subsets. Eur J
Immunol 42:2215–2220Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
